One of Eli Lilly’s most promising new obesity drugs helped patients lose about 28.7% of their body weight while also reducing pain associated with knee osteoarthritis. The drug giant’s LLY stock was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback